Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients

Folia Biologica (Czech Republic)

Volumn 59, Issue 6, 2013, Pages 240-245

  Paulíková, Simona ^a   Chmelarova M ^a   Petera, J ^a   Palicka V ^a   Paulik A ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Cervical cancer; DNA methylation; Late toxicity; RAD51 gene family

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CONTROL; CANCER RISK; CELL CYCLE PHASE; CHEMORADIOTHERAPY; CPG ISLAND; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; PROMOTER REGION; RAD51L3 GENE; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; XRCC2 GENE;

CHEMORADIOTHERAPY; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84893762399     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Borgmann, K., Roper, B., El-Awady, R., Brackrock, S., Bigalke, M., Dörk, T., Alberti, W., Dikomey, E., Dahm-Daphi, J. (2002) Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother. Oncol. 64,141-152. (Pubitemid 35247891)
2. Ellenson, L. H., Wu, T. C. (2004) Focus on endometrial and cervical cancer. Cancer Cell 5, 533-538. (Pubitemid 38748915)
3. French, C. A., Masson, J. Y., Griffin, C. S., O'Regan, P., West, S. C., Thacker, J. (2002) Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J. Biol. Chem. 277,19322-19330. (Pubitemid 34967437)
4. Kawabata, M., Kawabata, T., Nishibori, M. (2005) Role of recA/RAD51 family proteins in mammals. Acta Med. Okayama 59,1-9. (Pubitemid 40459842)
5. Kitahara, O., Katagiri, T., Tsunoda, T., Harima, Y., Nakamura, Y. (2002) Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 4, 295-303. (Pubitemid 34755839)
6. Liu, Y., Masson, J. Y., Shah, R., O'Regan, P., West, S. C. (2004) RAD51C is required for Holliday junction processing in mammalian cells. Science 303, 243-246. (Pubitemid 38057577)
7. Masson, J. Y., Stasiak, A. Z., Stasiak, A., Benson, F. E., West, S. C. (2001) Complex formation by the human RAD51C and XRCC3 recombination repair proteins. Proc. Natl. Acad. Sci. USA 98, 8440-8446. (Pubitemid 32678047)
8. Nygren, A. O., Ameziane, N., Duarte, H. M., Vijzelaar, R. N., Waisfisz, Q., Hess, C. J., Schouten, J. P., Errami, A. (2005) Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 33, e128.
9. Rieger, K. E., Hong, W. J., Tusher, V. G., Tang, J., Tibshirani, R., Chu, G. (2004) Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc. Natl. Acad. Sci. USA 101, 6635-6640. (Pubitemid 38586026)
10. Sonoda, E., Sasaki, M. S., Buerstedde, J. M., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y., Takeda, S. (1998) Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17, 598-608. (Pubitemid 28045499)
11. Svensson, J. P., Stalpers, L. J., Esveldt-van Lange, R. E., Franken, N. A., Haveman, J., Klein, B., Turesson, I., Vrieling, H., Giphart-Gassler, M. (2006) Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med. 3, e422.
12. Thacker, J., Zdzienicka, M. Z. (2004) The XRCC genes: expanding roles in DNA double-strand break repair. DNA Repair (Amst.) 3,1081-1090. (Pubitemid 38997951)
13. Thacker, J. (2005) The RAD51 gene family, genetic instability and cancer. Cancer Lett. 219, 125-35. (Pubitemid 40269475)
14. Turesson, I., Nyman, J., Holmberg, E., Oden, A. (1996) Prognostic factors for acute and late skin reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 36, 1065-1075. (Pubitemid 27014492)
15. Zempolich, K., Fuhrman, C., Milash, B., Flinner, R., Greven, K., Ryu, J., Forbes, A., Kerlin, K., Nichols, R. C., Gaffney, D. K. (2008) Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128. Gynecol. Oncol. 109, 275-279.
16. Zhu, C., Bogue, M. A., Lim, D. S., Hasty, P., Roth, D. B. (1996) Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-89. (Pubitemid 26272078)